Salk research focuses on the development of compounds that may protect against the diseases of aging, such as Alzheimer’s
Old age is the greatest risk factor for many diseases, including Alzheimer’s disease (AD) and cancer. Geroprotectors are a recently identified class of anti-aging compounds. New Salk research has now identified a unique subclass of these compounds, dubbed geroneuroprotectors (GNPs), which are AD drug candidates and slow the aging process in mice.
“The argument for geroprotectors is that if one can extend the lifespan of model organisms, such as mice, and translate this effect to humans, then you should be able to slow down the appearance of many diseases that are associated with aging, such as Alzheimer’s, Parkinson’s, cancer and overall frailty,” says first author Dave Schubert, Salk professor and head of Salk’s Cellular Neurobiology Laboratory.
The study, which appeared in the journal Trends in Pharmacological Sciences, on November 13, 2018, was conducted in collaboration with Salk Senior Staff Scientist Pamela Maher, whose lab is in the Cellular Neurobiology department and who is the study’s senior author.
The team started with two chemicals found in plants that have demonstrated medicinal properties: fisetin, a natural product derived from fruits and vegetables, and curcumin, from the curry spice turmeric. From these, the team synthesized three AD drug candidates based upon their ability to protect neurons from multiple toxicities associated with the aging brain. The lab showed that these three synthetic candidates (known as CMS121, CAD31 and J147), as well as fisetin and curcumin, reduced the molecular markers of aging, as well as dementia, and extended the median lifespan of mice or flies.
Importantly, the group demonstrated that the molecular pathways engaged by these AD drug candidates are the same as two other well-researched synthetic compounds that are known to extend the lifespan of many animals. For this reason, and based on the results of their previous studies, the team says fisetin, curcumin and the three AD drug candidates all meet the definition of being geroneuroprotectors.
The group is now focusing on getting two GNPs into human clinical trials. The fisetin derivative, CMS121, is currently in the animal toxicology studies required for FDA approval to start clinical trials. The curcumin derivative, J147, is under FDA review for allowance to start clinical trials for AD early next year. The group plans to incorporate biochemical markers for aging into the clinical trials to assay for potential geroprotective effects.
“Since we found that the natural products curcumin and fisetin are also GNPs and commercially available as supplements, they could provide some therapeutic benefits right now,” says Maher.
Other studies in the lab are determining whether these compounds have effects on organs outside of the brain. “If these drugs have benefits for other body systems, such as maintaining kidney function and overall muscle health, they could be used in additional ways to treat or prevent the diseases of aging,” Schubert says.
The investigators say that the discovery of these AD drug candidates validates the drug discovery model they have developed as a plausible method for identifying additional GNP compounds that will help promote healthy aging. This could greatly accelerate the pipeline for drugs to treat the diseases of aging for which there are currently no cures.
The Latest on: Anti-aging
[google_news title=”” keyword=”anti-aging” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Anti-aging
- Collagen for anti-aging: Do you know these facts about collagen supplements?on November 19, 2022 at 11:00 pm
The craze around collagen is hard to ignore, and the fad continues to spread across the country. That explains why consumers are left wondering if the touted benefits really live up to the ...
- ‘Anti-aging’ pills linked to increased cancer risk: studyon November 18, 2022 at 3:24 pm
A new study from the University of Missouri found a popular supplement used for a variety of beneficial health results may actually be responsible for heightening the risk of some cancers. The ...
- Popular ‘anti-aging’ supplement may lead to brain cancer, study sayson November 18, 2022 at 10:29 am
A study by researchers at the University of Missouri found that taking a popular vitamin supplement may contribute to risks of brain cancer. The vitamin, called nicotinamide riboside, is a variant of ...
- Anti-aging science: In search of eternal youthon November 17, 2022 at 12:36 pm
But he acknowledges that the hydra could help scientists decipher the molecular mechanisms that cause aging in humans. This question has been challenging the scientific community for decades, but ...
- Popular ‘anti-aging’ supplement may lead to brain cancer, study sayson November 17, 2022 at 10:23 am
Known for its suggested benefits to metabolism, brain health, and cardiovascular systems, nicotinamide riboside, or NR for short, is sometimes referred to as an “anti-aging” vitamin.
- The American Academy of Anti-Aging Medicine (A4M) Prepares for Largest World Congress in Commemoration Of 30th Anniversaryon November 17, 2022 at 7:32 am
The world's biggest and most anticipated longevity conference will feature an interactive agenda of ground-breaking education delivered by a stellar panel of renowned speakers from around the ...
- Anti-Aging Market with Highly productive Segment to Expand outstandingly | Including 125 Pages Reporton November 16, 2022 at 9:16 pm
Anti-Aging Market [Spreadsheet of 125 Pages] explore investment in Market. It classify how companies deploying ...
- Anti-Aging Market Size to Grow at 5.9% CAGR During the Forecast Period of 2022-2030 | Growth Plus Reportson November 14, 2022 at 11:34 pm
The growing geriatric population across the world plays as a major driver in the anti-aging market. The utilization of various products and the growing application of different treatments for ...
- Anti-Aging Market Size to Grow at 5.9% CAGR During the Forecast Period of 2022-2030 | Growth Plus Reportson November 14, 2022 at 11:29 pm
Pune, Nov. 15, 2022 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global Anti-Aging Market will clock US$ 70.53 billion by 2030. The rapidly increasing ...
via Bing News